U.S. markets closed

La Jolla Pharmaceutical Company (LJPC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.86+0.06 (+1.03%)
At close: 4:00PM EST

5.73 -0.13 (-2.22%)
After hours: 7:32PM EST

La Jolla Pharmaceutical Company

4550 Towne Centre Court
San Diego, CA 92121
United States
858 207 4264
http://lajollapharmaceutical.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees90

Key Executives

NameTitlePayExercisedYear Born
Dr. Lakhmir S. ChawlaConsultant560.21kN/A1971
Mr. Larry G. EdwardsPres, CEO & DirectorN/AN/A1972
Mr. Michael S. HearneCFO, Principal Financial & Accounting OfficerN/AN/A1963
Ms. Paula RusuVP of OperationsN/AN/AN/A
Ms. Sandra VedrickSr. Director of Investor Relations & HRN/AN/AN/A
Mr. Thomas OuelletteVP of Sales & MarketingN/AN/AN/A
Mr. Luke SeikkulaSr. VP of Pharmaceutical OperationsN/AN/A1964
Mr. Stewart M. KrollChief Devel. OfficerN/AN/A1959
Mr. Mark D. WilliamsSr. VP of Medical AffairsN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.

Corporate Governance

La Jolla Pharmaceutical Company’s ISS Governance QualityScore as of December 2, 2020 is 6. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 2; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.